<i>GATA6</i> mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33054971.
- Also identified by DOI 10.7554/eLife.53278 and PMC identifier 7593088.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Damaging <i>GATA6</i> variants cause cardiac outflow tract defects, sometimes with pancreatic and diaphragmic malformations. To define molecular mechanisms for these diverse developmental defects, we studied transcriptional and epigenetic responses to <i>GATA6</i> loss of function (LoF) and missense variants during cardiomyocyte differentiation of isogenic human induced pluripotent stem cells. We show that GATA6 is a pioneer factor in cardiac development, regulating <i>SMYD1</i> that activates <i>HAND2,</i> and <i>KDR</i> that with <i>HAND2</i> orchestrates outflow tract formation. LoF variants perturbed cardiac genes and also endoderm lineage genes that direct <i>PDX1</i> expression and pancreatic development. Remarkably, an exon 4 <i>GATA6</i> missense variant, highly associated with extra-cardiac malformations, caused ectopic pioneer activities, profoundly diminishing <i>GATA4</i>, <i>FOXA1/2,</i> and <i>PDX1</i> expression and increasing normal retinoic acid signaling that promotes diaphragm development. These aberrant epigenetic and transcriptional signatures illuminate the molecular mechanisms for cardiovascular malformations, pancreas and diaphragm dysgenesis that arise in patients with distinct <i>GATA6</i> variants.
Medical subject headings
- Diaphragm
- GATA6 Transcription Factor
- Heart
- Induced Pluripotent Stem Cells
- Pancreas